CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Biomerieux SA Company Snapshot
Biomerieux SA operates in the Diagnostic substances sector. In addition to historical fundamental analyses, the complete report available to purchase compares Biomerieux SA with three other pharmaceutical manufacturers in Europe: Stada Arzneimittel AG of Germany (2018 sales of 2.33 billion Euro [US$2.58 billion] of which 59% was Generics), Ipsen SA (2.35 billion Euro [US$2.60 billion] of which 82% was Specialty Care), and H. Lundbeck A/S which is based in Denmark (18.12 billion Danish Kroner [US$2.69 billion] of which 100% was Pharmaceuticals).

Sales Analysis. Biomerieux SA reported sales of 2.42 billion Euro (US$2.68 billion) for the year ending December of 2018. This represents an increase of 5.8% versus 2017, when the company's sales were 2.29 billion Euro. Sales at Biomerieux SA have increased during each of the previous five years (and since 2013, sales have increased a total of 52%). Sales of Diagnostic Clinical Equipment saw an increase of 7.4% in 2018, from 1.85 billion Euro to 1.99 billion Euro.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Biomerieux SA
  Stock Performance Chart for Biomerieux SA
 
  Stock Data: Recent Stock Performance:
  Current Price (9/13/2019): 70.20
(Figures in Euro)
1 Week 0.0%   13 Weeks -5.1%  
4 Weeks -6.1%   52 Weeks -7.6%  
 
Biomerieux SA Key Data:
  Ticker: BIM Country: France
  Exchanges: PAR Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Diagnostic Substances
  2018 Sales 2,421,300,000
(Year Ending Jan 2019).
Employees: 11,094
  Currency: Euro Market Cap: 8,307,603,275
  Fiscal Yr Ends: December Shares Outstanding: 118,341,927
  Share Type: Actions Ordinaires Closely Held Shares: 76,314,400
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.